Precision Biopsy closes $2.5M funding
Precision Biopsy  LLC recently closed a $2.5 million round of funding to help move the commercialization phase of a novel prostate cancer detection technology forward. The new technology was developed at the University of Colorado Anschutz Medical Campus.
Precision Biopsy is a privately-held company  created by Allied Minds  Inc. of Quincy in 2008. The startup focuses on optical biopsy technology designed to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer.